Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Symrise & Probi Enter R&D Agreement - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Symrise & Probi Enter R&D Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

German company Symrise AG and the probiotics company Probi AB, Lund, Sweden, have signed a joint research and developmentagreement.In response to the growing need for turnkey product solutions with proven healthbenefits, both companies have announced plans to collaborate oninnovative projects, initially focusing on oral health applications. Symrise AG currently holds a 14.97% minority share of Probi and may increasethis stake in the future.

Symrise has expertise in the research, development and manufacturing of food,beverages, cosmetics and pharmaceutical products and sees increasingpotential in the health benefits of probiotics. The company combines the abilityand the network to perform efficacy screening with the necessary know-how ofapplying active ingredients. Further, Symrise holds a globally leading positionin the area of oral care.

Probi’s experience is in the research,development and manufacturing of probiotics, and sells gut and immune health probiotics available on the world market.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics